{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Optimal Size Criteria for Lateral Lymph Node Dissection After Neoadjuvant Chemoradiotherapy for Rectal Cancer

Activity Steps


The certificate for this activity is for PHYSICIANS.

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Outline the indications for lateral lymph node dissection
  2. Describe the impact of lateral lymph node dissection on local recurrence rates
  3. Define the survival prognosis of a malignant lateral lymph node
Price: $10.00


  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: DCR0321
Published: March 2021
Expires: 3/31/2024
Required Passing Score: 3/4 (75%)
Authors: Kazushige Kawai, M.D., Hiroshi Shiratori, M.D., Keisuke Hata, M.D., Ph.D., Hiroaki Nozawa, M.D., Ph.D., Toshiaki Tanaka, M.D., Ph.D., Takeshi Nishikawa, M.D., Koji Murono, M.D., Ph.D. and Soichiro Ishihara, M.D., Ph.D.
Categories: Cancer , Surgical